Sacubitril/valsartan eligibility and outcomes in the ESC HFA EORP Heart Failure Long-Term Registry: bridging between the PARADIGM-HF trial, ESC Guidelines and real-world
27 May 2019 (16:45 - 16:55)
Organised by:
Slides
About the speaker
Attikon University Hospital, Athens (Greece)
10 More presentations in this session
Professor K. Sliwa (Cape Town, ZA)
Access the full session
The Event
Heart Failure 2019
27 May 2019
16:45 CET
You may be interested in
Congress Presentation
Congress Session
Congress Session
Congress Presentation
